SPARIAN BIOSCIENCES
Sparian Biosciences is an early-stage CNS-focused biopharmaceutical firm focusing on creating unique, transformative medicines for the central nervous system. They develop therapeutics targeting the brain through innovative science and novel drug discovery.
SPARIAN BIOSCIENCES
Industry:
Biotechnology Consulting Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.sparianbiosciences.com
Total Employee:
1+
Status:
Active
Official Site Inspections
http://www.sparianbiosciences.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sparian Biosciences"
About โ Sparian Biosciences
Sparian Biosciences is a clinical stage CNS-focused biopharmaceutical company committed to developing novel, transformational therapies. As neurologists and neuroscientists, co-founders โฆSee details»
Leadership โ Sparian Biosciences
Chris serves as head of manufacturing and development for Sparian. He has more than 25 years of industry experience with roles of increasing responsibility at AMRI, Johnson Matthey โฆSee details»
Sparian Biosciences โ Novel CNS Drugs
Sparian Biosciences is a clinical stage bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS).See details»
Sparian Biosciences - Crunchbase Company Profile
Sparian Biosciences is an early-stage CNS-focused biopharmaceutical firm focusing on creating unique, transformative medicines for the central nervous โฆSee details»
Sparian Biosciences - LinkedIn
Sparian Biosciences is a clinical stage CNS-focused biopharmaceutical company committed to developing novel, transformational therapies. As neurologists and neuroscientists, co-founders Jeff Reich ...See details»
Sparian Biosciences - Org Chart, Teams, Culture & Jobs - The Org
View Sparian Biosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Sparian Biosciences, Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sparian Biosciences, Inc of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Sparian Biosciences, Inc - VentureRadar
Website: https://www.sparianbiosciences.com/ Develops novel, transformational therapies for central nervous system diseases, addressing a major unmet need and ...See details»
Sparian Biosciences - 2025 Company Profile - Tracxn
Apr 27, 2025 Sparian Biosciences - Developer of therapies for central nervous system disorders. Raised funding over 1 round from 1 investor. Founded by Gavril Pasternak in the year 2018. โฆSee details»
Sparian Biosciences Announces Formation of its Science Advisory โฆ
Nov 13, 2024 Sparian has five programs that address acute and chronic pain, opioid use disorder (OUD), acute opioid overdose, and stimulant use disorder (StUD). Sparian is the โฆSee details»
Sparian Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Sparian Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 5 news, Disease Domain:Nervous System Diseases ...See details»
Sparian Biosciences Profile - HigherGov
Sparian Biosciences (UEI E6GKXJ7MWV68, CAGE 8EU60) based in New York NY federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Sparian Biosciences - Products, Competitors, Financials, Employees ...
Sparian Biosciences is a clinical stage bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS). Use the CB Insights โฆSee details»
Sparian Biosciences 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Sparian Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Sparian Biosciences Announces Formation of its Science
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Sparian Biosciences, Inc. (โSparianโ), a clinical-stage CNS-focused biopharmaceutical company, is proud to announce formation of a โฆSee details»
Sparian Biosciences, Inc. (Sparian Biosciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Sparian is the recipient of three NIDA UG3/UH3 grants and an SBIR grant totaling over $60M in NIH support. For more information, visit www.Sparianbiosciences.com. Research reported in โฆSee details»
Sparian Biosciences - Overview, News & Similar companies
Feb 23, 2023 www.sparianbiosciences.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Sparian Biosciences Awarded Five-Year โฆSee details»
Contact Us โ Sparian Biosciences
Sparian Biosciences, Inc. [email protected]. BioLabs 180 Varick Street, Suite 615 New York, NY 10014. Cambridge Innovation Center 1 Broadway, 14th FloorSee details»
SBS-147 - Drug Targets, Indications, Patents - Synapse
Sparian is the recipient of two NIDA UG3/UH3 grants and an SBIR grant totaling nearly $41M in NIH support. For more information, visit www.Sparianbiosciences.com. Research reported in โฆSee details»
Publications โ Sparian Biosciences
Katz, J. L., Hiranita, T., Hong, W. C., Job, M. O., & McCurdy, C. R. (2017). A role for sigma receptors in stimulant self-administration and addiction.See details»